$ China Med Intl Stock (5IB) - Price and Fundamental Data | DZHI - DZH International
$ China Med Intl (5IB)

Company Info and Fundamentals

Principal Activities
China Medical (International) Group Limited together with its subsidiary corporations (the “Group”) started its distribution and agency business in 1987, supplying quality products and related solutions for the metal industries in ASEAN.
The Group represent international producers in the distribution of a range of raw materials, consumables and disposable supplies, measuring systems, equipment and engineering spares for steel melting plants, steel rolling mills, cast iron and steel foundries.
In November 2015, the Group diversified into the aesthetics medical and healthcare sector with the acquisition of a majority stake in China iMyth Company Pte. Ltd. (“China iMyth”) which holds an aesthetics medical practice in Taipei. China iMyth focuses on aesthetics medicine including botox, laser treatments, plastic surgery, anti-ageing treatments and detoxification. China iMyth also intends to expand into People’s Republic of China by partnering and collaborating with aesthetics clinics in Shenzhen and eventually to other cities.
China Medical’s other interest in People’s Republic of China includes a kidney hospital and an aesthetics medical clinic in Qingdao, a city in the eastern Shandong province.

Full NameChina Medical (International) Group LimitedStock No5IB
ExchangeSingapore Exchange (SGX)BoardCatalist
Exchange SectorCommerceYear-End31-Dec
Par Value (SGD)0.0000Issued Shares (Mil)2999.1330
Paid-Up Cap. (SGD Mil)50.0000Market Capitalization (Mil)2.9991
Share Price (SGD)
Current Price0.00
Previous Cloe0.00
Week High0.00
Week Low0.00
Month High0.00
Month Low0.00
52-week High0.00
52-week Low0.00
Share Price Performance(%)
MTD change-100.0000
YTD change-100.0000
Today Volume('000)0
100-day Average Daily Volume ('000)14,026.76
Technical Indicators-A shapshot
Ratio (Daily)
Dividend Yield0.00
P/E ratio-0.34
Financial Ratios
Exchange Rate*---
Profitability Ratio
Return on Equity362.041-699.851-10.643
Return on Revenue-555.007-591.672-33.675
Liquidity Ratio
Return on Equity0.9720.8190.945
Return on Revenue0.9620.8060.859
Gross Eps (cents) *-0.290-0.650-0.100
Dividend (cents) *0.0000.0000.000
* Calculation is based on the specific Currency Exchange Rate
Assets and Liabilities 2015-2017
Financial Statement
Balance Sheet
Period Start2017-01-012016-01-012015-01-01
Period End2017-12-312016-12-312015-12-31
Current Assets4,441.004,159.004,751.00
Current Liabilities4,569.005,078.005,027.00
Long-term Assets76.007,570.0018,525.00
Shareholders Fund-3,322.002,680.0017,607.00
Minority Interest92.00-64.00616.00
Long-term Liabilities3,178.004,035.0026.00
Financial Statement
Balance Sheet
Period Start2017-01-012016-01-012015-01-01
Period End2017-12-312016-12-312015-12-31
Profit/loss Before Tax-12,120.00-19,438.00-1,304.00
Minority Interest103.00680.00-565.00
Net Profit/loss To Shareholders-12,027.00-18,756.00-1,874.00
Financial Statement
Cashflow Statement
Period Start2017-01-012016-01-012015-01-01
Period End2017-12-312016-12-312015-12-31
Cash Flows From Operating Activities-3,071.00-12,266.001,861.00
Cash Flows From Investing Activities-10.00-86.00-10,843.00
Cash Flows From Financing Activities4,892.0011,816.003,193.00
Net Changes In Cash And Cash Equivalents1,811.00-536.00-5,789.00
Cash And Cash Equivalents Brought Forward1,533.002,061.007,808.00
Cash And Cash Equivalents Carried Forward3,344.001,525.002,019.00
Historical Prices
OpenHighLowCloseVol('000)O/C RangeH/L Range
Time and Sales

Warning: Invalid argument supplied for foreach() in /WWW/next/stock_overview.php on line 412

Warning: arsort() expects parameter 1 to be array, null given in /WWW/next/stock_overview.php on line 423

Warning: implode(): Invalid arguments passed in /WWW/next/stock_overview.php on line 424
TypeLast DoneChangeVolume ('000)